Investor FAQs

Show All
On what stock exchange are Krystal Biotech shares traded, and what is the ticker symbol?
NASDAQ GS: (KRYS)
Where is Krystal Biotech's corporate headquarters?

Krystal Biotech, Inc.
2100 Wharton Street, # 701
Pittsburgh, PA 15203-1973

U.S. Mailing Address
Krystal Biotech, Inc.
2100 Wharton Street, # 701
Pittsburgh, PA 15203-1973

Who are the members of the Krystal Biotech team?

You can view us by visiting the TEAM section of our website.

When does Krystal Biotech's fiscal year end?

31 December

Where can I find all of Krystal Biotech's SEC filings? Where can I download and view quarterly and annual reports?

Quarterly and annual reports, as well as other SEC filings, can be accessed on the Financial Information portion of our Investor Relations website or directly from the SEC at www.sec.gov

How can I contact Krystal Biotech’s transfer agent regarding my shares?

Fidelity Stock Transfer℠ (FST) is Krystal Biotech’s transfer agent and registrar. You may contact FST with questions about your share ownership through any of the methods below:

 

Phone: (833) 500-1036 (toll-free)
Representatives are available Monday through Friday, 8:00 a.m. to 8:00 p.m. EST.

 

Online:
If you have an existing account through Fidelity.com or NetBenefits.com, you can log in to view your account holdings by navigating to the Registered Stock section.

 

Email: FSTOperations@fmr.com

 

Mail:
Fidelity Investments
Attn: Fidelity Stock Transfer Solutions
PO Box 770017
Cincinnati, OH 45277

 

Overnight Mail:
Fidelity Investments
Attn: Fidelity Stock Transfer Solutions
100 Crosby Parkway
Mail Zone KY16
Covington, KY 41015

 

Do you have another question that hasn't been answered?

Please submit your questions here.

Show all

NASDAQ (KRYS)
Krystal Biotech, Inc.
2100 Wharton Street, # 701
Pittsburgh, PA 15203-1973

U.S. Mailing Address
Krystal Biotech, Inc.
2100 Wharton Street, # 701
Pittsburgh, PA 15203-1973
You can view us by visiting the TEAM section of our website.
31 December
Quarterly and annual reports, as well as other SEC filings, can be accessed on the Financial Information portion of our Investor Relations website or directly from the SEC at www.sec.gov
Please submit your questions here.